Financial Counselors Inc Abbott Laboratories Transaction History

Financial Counselors Inc

  • $6.76 Billion
  • Q4 2024

A detailed history of Financial Counselors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Counselors Inc holds 52,335 shares of ABT stock, worth $6.84 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
52,335
Previous 51,903 0.83%
Holding current value
$6.84 Million
Previous $5.92 Million 0.03%
% of portfolio
0.09%
Previous 0.09%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$111.93 - $119.39 $48,353 - $51,576
432 Added 0.83%
52,335 $5.92 Million
Q3 2024

Nov 13, 2024
SELL
$100.07 - $118.13 $17,212 - $20,318
-172 Reduced 0.33%
51,903 $5.92 Million
Q2 2024

Aug 01, 2024
SELL
$100.73 - $112.44 $174,162 - $194,408
-1,729 Reduced 3.21%
52,075 $5.41 Million
Q1 2024

May 02, 2024
BUY
$109.52 - $120.96 $92,434 - $102,090
844 Added 1.59%
53,804 $6.12 Million
Q4 2023

Jan 26, 2024
BUY
$90.19 - $110.4 $86,943 - $106,425
964 Added 1.85%
52,960 $5.83 Million
Q3 2023

Nov 07, 2023
SELL
$95.53 - $114.62 $28,181 - $33,812
-295 Reduced 0.56%
51,996 $5.04 Million
Q2 2023

Jul 27, 2023
SELL
$100.78 - $112.29 $7,457 - $8,309
-74 Reduced 0.14%
52,291 $5.7 Million
Q1 2023

May 02, 2023
SELL
$96.86 - $114.01 $364,581 - $429,133
-3,764 Reduced 6.71%
52,365 $5.3 Million
Q4 2022

Feb 14, 2023
BUY
$95.06 - $111.52 $228,334 - $267,871
2,402 Added 4.47%
56,129 $6.16 Million
Q3 2022

Nov 01, 2022
SELL
$96.76 - $112.03 $524,342 - $607,090
-5,419 Reduced 9.16%
53,727 $5.2 Million
Q2 2022

Aug 02, 2022
BUY
$102.07 - $123.37 $639,774 - $773,283
6,268 Added 11.85%
59,146 $6.43 Million
Q1 2022

Apr 28, 2022
BUY
$114.02 - $139.04 $845,686 - $1.03 Million
7,417 Added 16.32%
52,878 $6.26 Million
Q4 2021

Feb 10, 2022
SELL
$115.53 - $141.46 $2.68 Million - $3.29 Million
-23,226 Reduced 33.81%
45,461 $6.4 Million
Q3 2021

Oct 26, 2021
SELL
$116.66 - $129.06 $115,376 - $127,640
-989 Reduced 1.42%
68,687 $8.11 Million
Q2 2021

Aug 03, 2021
BUY
$105.79 - $124.53 $200,154 - $235,610
1,892 Added 2.79%
69,676 $8.08 Million
Q1 2021

Apr 29, 2021
SELL
$108.84 - $128.23 $18,720 - $22,055
-172 Reduced 0.25%
67,784 $8.12 Million
Q4 2020

Feb 10, 2021
SELL
$105.0 - $114.42 $238,140 - $259,504
-2,268 Reduced 3.23%
67,956 $7.44 Million
Q3 2020

Nov 16, 2020
SELL
$91.64 - $111.29 $728,263 - $884,421
-7,947 Reduced 10.17%
70,224 $7.64 Million
Q2 2020

Aug 07, 2020
BUY
$76.57 - $98.0 $2.45 Million - $3.13 Million
31,943 Added 69.1%
78,171 $7.15 Million
Q1 2020

Apr 23, 2020
SELL
$62.82 - $91.86 $150,642 - $220,280
-2,398 Reduced 4.93%
46,228 $3.65 Million
Q4 2019

Jan 31, 2020
BUY
$78.51 - $87.4 $549 - $611
7 Added 0.01%
48,626 $4.22 Million
Q3 2019

Nov 08, 2019
SELL
$81.84 - $88.74 $65,881 - $71,435
-805 Reduced 1.63%
48,619 $4.07 Million
Q2 2019

Aug 14, 2019
SELL
$72.88 - $85.0 $59,397 - $69,275
-815 Reduced 1.62%
49,424 $4.16 Million
Q1 2019

May 10, 2019
SELL
$66.22 - $80.06 $350,502 - $423,757
-5,293 Reduced 9.53%
50,239 $4.02 Million
Q4 2018

Feb 01, 2019
SELL
$65.56 - $74.27 $142,527 - $161,462
-2,174 Reduced 3.77%
55,532 $4.02 Million
Q3 2018

Oct 30, 2018
SELL
$60.81 - $73.36 $23,898 - $28,830
-393 Reduced 0.68%
57,706 $4.23 Million
Q2 2018

Aug 03, 2018
SELL
$57.57 - $63.54 $26,885 - $29,673
-467 Reduced 0.8%
58,099 $3.54 Million
Q1 2018

Apr 26, 2018
SELL
$56.27 - $63.62 $240,723 - $272,166
-4,278 Reduced 6.81%
58,566 $3.51 Million
Q4 2017

Feb 12, 2018
BUY
$53.68 - $57.47 $121,370 - $129,939
2,261 Added 3.73%
62,844 $3.59 Million
Q3 2017

Nov 13, 2017
BUY
$48.06 - $53.64 $96,071 - $107,226
1,999 Added 3.41%
60,583 $3.23 Million
Q2 2017

Aug 10, 2017
BUY
N/A
58,584
58,584 $2.85 Million

Others Institutions Holding ABT

# of Institutions
3,336
Shares Held
1.36B
Call Options Held
10M
Put Options Held
9.48M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Counselors Inc Portfolio

Follow Financial Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email